2-methoxy-N,N-dimethyl-5-nitrobenzenemethanamine | 116791-95-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-methoxy-N,N-dimethyl-5-nitrobenzenemethanamine
• 英文别名: N-(2-methoxy-5-nitrophenylmethyl)dimethylamine；N,N-dimethyl-N-(2-methoxy-5-nitrobenzyl)amine；1-(2-methoxy-5-nitrophenyl)-N,N-dimethylmethanamine
• CAS: 116791-95-8
• 化学式: C₁₀H₁₄N₂O₃
• mdl: MFCD26395554
• 分子量: 210.233
• InChiKey: XNPCXLICDYYJIG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-methoxy-N,N-dimethyl-5-nitrobenzenemethanamine 生成 3-N-dimethylamino-methyl-4-methoxy aniline
  参考文献：
  名称：

  IBRAHIM, EL-SAYED;MONTGOMERIE, ANITA M.;SNEDDON, ANDREW H.;PROCTOR, GEORG+, EUR. J. MED. CHEM., 23,(1988) N 2, 183-188

  摘要：

  DOI：
• 作为产物：
  描述：

  2-溴-5-硝基甲苯 以82%的产率得到2-methoxy-N,N-dimethyl-5-nitrobenzenemethanamine
  参考文献：
  名称：

  Aniline derivatives possessing an inhibitory effect of nitric oxide synthase

  摘要：

  由一般式（1）表示的化合物：（其中R1为SR6或NR7R8，其中R6通常为具有1-6个碳原子的烷基基团，R7为氢原子、具有1-6个碳原子的烷基基团或硝基基团，R8为氢原子或具有1-6个碳原子的烷基基团；R2和R3通常为氢原子或具有1-6个碳原子的烷基基团；R4为氢原子、具有1-6个碳原子的烷基基团或其胺部分可能被烷基或硝基基团取代的酰胺基团；R5为氢原子或具有1-6个碳原子的烷基基团；Y1、Y2、Y3和Y4可能相同或不同，通常为氢原子、卤素原子或具有1-6个碳原子的烷氧基团；n和m各自为0或1的整数），或这些化合物的可能立体异构体或光学活性形式，或其药学上可接受的盐。这些化合物具有强效的一氧化氮合酶抑制活性，并可用作脑血管疾病的治疗药物。

  公开号：

  US06534546B1

文献信息

• Quinazoline derivatives for use against cancer
  申请人：Ple Patrick

  公开号：US20090036474A1

  公开（公告）日：2009-02-05

  The invention concerns quinazoline derivatives of Formula (I) or a pharmaceutically-acceptable salt, solvate or pro-drug thereof, wherein each of p, R 1 , q, R 2 , R 3 , R 4 , R 5 , Ring A, X 1 , R 6 , r and R 7 has any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders or in the treatment of disease states associated with angiogenesis and/or vascular permeability.

  该发明涉及式（I）的喹唑啉衍生物或其药学上可接受的盐、溶剂或前药，其中p、R1、q、R2、R3、R4、R5、环A、X1、R6、r和R7中的每一个具有描述中定义的任何含义；它们的制备过程、含有它们的制药组合物以及它们在制造用于治疗细胞增殖性疾病或与血管生成和/或血管通透性相关的疾病状态的药物中的使用。
• Synthesis and antifilarial activity of N-[4-[[4-alkoxy-3-[(dialkylamino)methyl]phenyl]amino]-2-pyrimidinyl]-N'-phenylguanidines
  作者：Mario Angelo、Daniel Ortwine、Donald Worth、Leslie M. Werbel、John W. McCall

  DOI：10.1021/jm00363a010

  日期：1983.9

  A series of N-[4-[[4-alkoxy-3-[(dialkylamino)methyl]phenyl]amino]- 2-pyrimidinyl]-N'-phenylguanidines have been synthesized for antifilarial evaluation. Reaction of the appropriate benzenamines with N-cyanoguanidine, followed by condensation of the resultant N-phenylimidodicarbonimidic diamides (V) with ethyl 4,4,4-trifluoro-3-oxobutanoate provided the intermediate N-(4-hydroxy-2-pyrimidinyl)-N'-phenylguanidines VIa. Alternatively, compounds VIa were synthesized by reaction of the requisite beta-keto esters (VII) with N-cyanoguanidine to give the (4-hydroxy-2-pyrimidinyl)cyanamides (VIII), followed by treatment with the desired benzenamines. Chlorination with POCl3 and condensation with the appropriate benzenamines (IX) generated the desired guanidines (X). Antifilarial activity was confined to adult Litomosoides carinii infections, and a structure-activity relationship for this activity is discussed. Lack of activity against L. carinii microfilaria and adult Brugia pahangi infections preclude further work in this area pending evaluation in additional experimental models.
• IBRAHIM, EL-SAYED;MONTGOMERIE, ANITA M.;SNEDDON, ANDREW H.;PROCTOR, GEORG+, EUR. J. MED. CHEM., 23,(1988) N 2, 183-188
  作者：IBRAHIM, EL-SAYED、MONTGOMERIE, ANITA M.、SNEDDON, ANDREW H.、PROCTOR, GEORG+

  DOI：——

  日期：——
• ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY
  申请人：Chugai Seiyaku Kabushiki Kaisha

  公开号：EP0798292B1

  公开（公告）日：2004-11-03
• US6534546B1
  申请人：——

  公开号：US6534546B1

  公开（公告）日：2003-03-18